Chronic Hepatitis B Clinical Trials

531 clinical trials for Chronic Hepatitis B across international registries, including 49 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) — RECRUITING · PHASE2
• VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B — RECRUITING · PHASE2
• A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B — RECRUITING · PHASE2
• Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection — RECRUITING
• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function. — RECRUITING · PHASE1
• A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs — RECRUITING · PHASE2
• Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease — RECRUITING
• Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B — RECRUITING · PHASE2
• ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection — RECRUITING · PHASE4
• Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection — RECRUITING
• A first in human study of people with chronic hepatitis B, where all participants will receive the new drug PBGENE-HBV. This study will use increasing dose amounts of the drug to see how safe and bearable it is. The study will also test how well PBGENE-HBV works and how it is processed by the body. — RECRUITING · PHASE1
• TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate — RECRUITING · PHASE1
• Adaptability of an Undetectable = Untransmissible Model for HBV — RECRUITING
• Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare — RECRUITING · NA
• Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients — RECRUITING · NA
• Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection — RECRUITING
• SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus — RECRUITING · PHASE4
• MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B — RECRUITING
• To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment — RECRUITING · PHASE3
• Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B — RECRUITING · PHASE1
• A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B — RECRUITING · PHASE3
• SA1211 Injection Phase 1 Study — RECRUITING · PHASE1
• Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance — RECRUITING
• A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B — RECRUITING · PHASE2
• TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B — RECRUITING · PHASE1
• Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B — RECRUITING
• Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project. — RECRUITING
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) — RECRUITING · PHASE2
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B) — RECRUITING · PHASE2
• Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B — RECRUITING · PHASE2
• Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women — RECRUITING · PHASE4
• HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients — RECRUITING · PHASE1
• Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) — RECRUITING · PHASE4
• A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B — RECRUITING · PHASE2
• From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients — RECRUITING · PHASE1
• Research on Clinical Recovery and Maintenance Strategies for CHB — RECRUITING · NA
• Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance — RECRUITING
• Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults — RECRUITING · NA
• A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B — RECRUITING · NA
• Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b — RECRUITING
• Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon — RECRUITING
• Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） — RECRUITING · PHASE4
• Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） — RECRUITING · NA
• PHASE II INVESTIGATOR-INITIATED STUDY TO UNDERSTAND THE VACCINAL EFFECT OF HBSAG MONOCLONAL AB VIR-3434 IN CHRONIC HEPATITIS B INFECTION — RECRUITING · PHASE2
• Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention. — RECRUITING · NA
• Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD — RECRUITING
• Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase — RECRUITING
• PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF HEPTCELL (ADJUVANTED FP-02.2) AS AN IMMUNOTHERAPEUTIC VACCINE IN TREATMENT NAÏVE PATIENTS WITH INACTIVE CHRONIC HEPATITIS B (CHB) — RECRUITING · PHASE2
• The Establishment of Korean Hepatitis B Patients Cohort — RECRUITING
• Research study, conducted in patients with chronic hepatitis B, during treatment with nucleos(t)ide analogues (NA), with the aim to assess the effect of the administration of peginterferon alfa-2a (PEG-IFN) for 48 weeks, on the improvement of treatment responses. — COMPLETED · PHASE2

Refine this search